만성 폐쇄성 폐질환 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "만성 폐쇄성 폐질환" in Korean language version.

refsWebsite

Global rank Korean rank

81nih.gov

4^th place

71doi.org

2^nd place

3^rd place

29google.ca

838^th place

317^th place

12web.archive.org

1^st place

6who.int

195^th place

98^th place

6goldcopd.org

low place

7,640^th place

2nice.org.uk

3,258^th place

1,025^th place

2books.google.com

3^rd place

9^th place

2atsjournals.org

low place

1semanticscholar.org

11^th place

310^th place

1plos.org

2,112^th place

1,114^th place

1ebmedicine.net

low place

2,649^th place

1thoracic.org

low place

1brit-thoracic.org.uk

low place

1nhs.uk

1,989^th place

944^th place

1hse.gov.uk

8,579^th place

4,207^th place

1chestnet.org

low place

1cdc.gov

218^th place

52^nd place

1ahrq.gov

9,469^th place

low place

1reference.com

657^th place

250^th place

1mhprofessional.com

low place

1thefreedictionary.com

614^th place

249^th place

1gov.uk

432^nd place

1,006^th place

1weforum.org

1,771^st place

697^th place

ahrq.gov

hcup-us.ahrq.gov

Torio CM; Andrews RM (2006). “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160”. 《Healthcare Cost and Utilization Project (HCUP) Statistical Briefs》 (Agency for Health Care Policy and Research). PMID 24199255. 2017년 3월 14일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.

atsjournals.org

ajrccm.atsjournals.org

Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J (September 2007). “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary”. 《Am. J. Respir. Crit. Care Med.》 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. PMID 17507545.

pats.atsjournals.org

Kennedy SM; Chambers R; Du W; Dimich-Ward H (December 2007). “Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?”. 《Proceedings of the American Thoracic Society》 4 (8): 692–4. doi:10.1513/pats.200707-094SD. PMID 18073405.

books.google.com

Anita Sharma; Barclay, Joyce (2010). 《COPD in primary care》. Oxford: Radcliffe Pub. 9쪽. ISBN 978-1-84619-316-3.
George L. Waldbott (1965). 《A struggle with Titans》. Carlton Press. 6쪽.

brit-thoracic.org.uk

BTS COPD Consortium (2005). “Spirometry in practice - a practical guide to using spirometry in primary care”. 8–9쪽. 2014년 8월 26일에 원본 문서에서 보존된 문서. 2014년 8월 25일에 확인함.

cdc.gov

Centers for Disease Control and Prevention (2012년 11월 23일). “Chronic Obstructive Pulmonary Disease Among Adults — United States, 2011”. 《Morbidity and Mortality Weekly Report》 61 (46): 938–43. PMID 23169314.

chestnet.org

journal.publications.chestnet.org

Liesker JJ; Wijkstra PJ; Ten Hacken NH; Koëter GH; Postma DS; Kerstjens HA (February 2002). “A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD”. 《Chest》 121 (2): 597–608. doi:10.1378/chest.121.2.597. PMID 11834677. 2015년 9월 28일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.

doi.org

dx.doi.org

Vogelmeier CF; Criner GJ; Martinez FJ; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Chen R; Decramer M; Fabbri LM; Frith P; Halpin DM; López Varela MV; Nishimura M; Roche N; Rodriguez-Roisin R; Sin DD; Singh D; Stockley R; Vestbo J; Wedzicha JA; Agusti A (April 2017). “Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary”. 《Respirology》 22 (3): 575–601. doi:10.1111/resp.13012. PMID 28150362.
Decramer M; Janssens W; Miravitlles M (April 2012). “Chronic obstructive pulmonary disease”. 《Lancet》 379 (9823): 1341–51. doi:10.1016/S0140-6736(11)60968-9. PMID 22314182.
Nathell L; Nathell M; Malmberg P; Larsson K (2007). “COPD diagnosis related to different guidelines and spirometry techniques”. 《Respir. Res.》 8 (1): 89. doi:10.1186/1465-9921-8-89. PMC 2217523. PMID 18053200.
Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J (September 2007). “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary”. 《Am. J. Respir. Crit. Care Med.》 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. PMID 17507545.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
GBD 2015 Mortality and Causes of Death Collaborators (October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Mathers CD; Loncar D (November 2006). “Projections of Global Mortality and Burden of Disease from 2002 to 2030”. 《PLoS Med.》 3 (11): e442. doi:10.1371/journal.pmed.0030442. PMC 1664601. PMID 17132052.
Mahler DA (2006). “Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease”. 《Proceedings of the American Thoracic Society》 3 (3): 234–8. doi:10.1513/pats.200509-103SF. PMID 16636091.
Holland AE; Hill CJ; Jones AY; McDonald CF (2012). Holland, Anne E, 편집. “Breathing exercises for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 10: CD008250. doi:10.1002/14651858.CD008250.pub2. PMID 23076942.
Weitzenblum E; Chaouat A (2009). “Cor pulmonale”. 《Chron Respir Dis》 6 (3): 177–85. doi:10.1177/1479972309104664. PMID 19643833.
Brulotte CA; Lang ES (May 2012). “Acute exacerbations of chronic obstructive pulmonary disease in the emergency department”. 《Emerg. Med. Clin. North Am.》 30 (2): 223–47, vii. doi:10.1016/j.emc.2011.10.005. PMID 22487106.
Laniado-Laborín, R (January 2009). “Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century”. 《International journal of environmental research and public health》 6 (1): 209–24. doi:10.3390/ijerph6010209. PMC 2672326. PMID 19440278.
Kennedy SM; Chambers R; Du W; Dimich-Ward H (December 2007). “Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?”. 《Proceedings of the American Thoracic Society》 4 (8): 692–4. doi:10.1513/pats.200707-094SD. PMID 18073405.
Pirozzi C; Scholand MB (July 2012). “Smoking cessation and environmental hygiene”. 《Med. Clin. North Am.》 96 (4): 849–67. doi:10.1016/j.mcna.2012.04.014. PMID 22793948.
Halbert RJ; Natoli JL; Gano A; Badamgarav E; Buist AS; Mannino DM (September 2006). “Global burden of COPD: systematic review and meta-analysis”. 《Eur. Respir. J.》 28 (3): 523–32. doi:10.1183/09031936.06.00124605. PMID 16611654.
Devereux, Graham (2006). “Definition, epidemiology and risk factors”. 《BMJ》 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. PMC 1459603. PMID 16690673.
Rushton, Lesley (2007). “Chronic Obstructive Pulmonary Disease and Occupational Exposure to Silica”. 《Reviews on Environmental Health》 22 (4): 255–72. doi:10.1515/REVEH.2007.22.4.255. PMID 18351226.
Foreman MG; Campos M; Celedón JC (July 2012). “Genes and chronic obstructive pulmonary disease”. 《Med. Clin. North Am.》 96 (4): 699–711. doi:10.1016/j.mcna.2012.02.006. PMC 3399759. PMID 22793939.
Brode SK; Ling SC; Chapman KR (September 2012). “Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease”. 《CMAJ》 184 (12): 1365–71. doi:10.1503/cmaj.111749. PMC 3447047. PMID 22761482.
Beasley, V; Joshi, PV; Singanayagam, A; Molyneaux, PL; Johnston, SL; Mallia, P (2012). “Lung microbiology and exacerbations in COPD”. 《International journal of chronic obstructive pulmonary disease》 7: 555–69. doi:10.2147/COPD.S28286. PMC 3437812. PMID 22969296.
Calverley PM; Koulouris NG (2005). “Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology”. 《Eur Respir J》 25 (1): 186–199. doi:10.1183/09031936.04.00113204. PMID 15640341.
O'Donnell DE (2006). “Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease”. 《The Proceedings of the American Thoracic Society》 3 (2): 180–4. doi:10.1513/pats.200508-093DO. PMID 16565429.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P (August 2011). “Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society”. 《Ann. Intern. Med.》 155 (3): 179–91. doi:10.7326/0003-4819-155-3-201108020-00008. PMID 21810710.
Torres M; Moayedi S (May 2007). “Evaluation of the acutely dyspneic elderly patient”. 《Clin. Geriatr. Med.》 23 (2): 307–25, vi. doi:10.1016/j.cger.2007.01.007. PMID 17462519.
Mackay AJ; Hurst JR (July 2012). “COPD exacerbations: causes, prevention, and treatment”. 《Med. Clin. North Am.》 96 (4): 789–809. doi:10.1016/j.mcna.2012.02.008. PMID 22793945.
Poole PJ; Chacko E; Wood-Baker RW; Cates CJ (2006). Poole, Phillippa, 편집. “Influenza vaccine for patients with chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (1): CD002733. doi:10.1002/14651858.CD002733.pub2. PMID 16437444.
Tønnesen P (March 2013). “Smoking cessation and COPD”. 《Eur Respir Rev》 22 (127): 37–43. doi:10.1183/09059180.00007212. PMID 23457163.
Drummond MB; Dasenbrook EC; Pitz MW; Murphy DJ; Fan E (November 2008). “Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis”. 《JAMA》 300 (20): 2407–16. doi:10.1001/jama.2008.717. PMID 19033591.
Carlucci A; Guerrieri A; Nava S (December 2012). “Palliative care in COPD patients: is it only an end-of-life issue?”. 《Eur Respir Rev》 21 (126): 347–54. doi:10.1183/09059180.00001512. PMID 23204123.
Puhan MA; Gimeno-Santos E; Scharplatz M; Troosters T; Walters EH; Steurer J (2011). Puhan, Milo A, 편집. “Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (10): CD005305. doi:10.1002/14651858.CD005305.pub3. PMID 21975749.
Lacasse Y; Goldstein R; Lasserson TJ; Martin S (2006). Lacasse, Yves, 편집. “Pulmonary rehabilitation for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (4): CD003793. doi:10.1002/14651858.CD003793.pub2. PMID 17054186.
Ferreira IM; Brooks D; White J; Goldstein R (2012). Ferreira, Ivone M, 편집. “Nutritional supplementation for stable chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 12: CD000998. doi:10.1002/14651858.CD000998.pub3. PMID 23235577.
van Dijk WD; van den Bemt L; van Weel C (2013). “Megatrials for bronchodilators in chronic obstructive pulmonary disease (COPD) treatment: time to reflect”. 《J Am Board Fam Med》 26 (2): 221–4. doi:10.3122/jabfm.2013.02.110342. PMID 23471939.
Liesker JJ; Wijkstra PJ; Ten Hacken NH; Koëter GH; Postma DS; Kerstjens HA (February 2002). “A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD”. 《Chest》 121 (2): 597–608. doi:10.1378/chest.121.2.597. PMID 11834677. 2015년 9월 28일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.
Chong J; Karner C; Poole P (2012). Chong, Jimmy, 편집. “Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 9: CD009157. doi:10.1002/14651858.CD009157.pub2. PMID 22972134.
Karner C; Cates CJ (2012). Karner, Charlotta, 편집. “Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 4: CD008989. doi:10.1002/14651858.CD008989.pub2. PMID 22513969.
Cave, AC.; Hurst, MM. (May 2011). “The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis”. 《Pharmacol Ther》 130 (2): 114–43. doi:10.1016/j.pharmthera.2010.12.008. PMID 21276815.
Spencer, S; Karner, C; Cates, CJ; Evans, DJ (2011년 12월 7일). Spencer, Sally, 편집. “Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease”. 《The Cochrane database of systematic reviews》 (12): CD007033. doi:10.1002/14651858.CD007033.pub3. PMID 22161409.
Wang, J; Nie, B; Xiong, W; Xu, Y (April 2012). “Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis”. 《Journal of clinical pharmacy and therapeutics》 37 (2): 204–11. doi:10.1111/j.1365-2710.2011.01285.x. PMID 21740451.
Decramer ML; Hanania NA; Lötvall JO; Yawn BP (2013). “The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease”. 《Int J Chron Obstruct Pulmon Dis》 8: 53–64. doi:10.2147/COPD.S39018. PMC 3558319. PMID 23378756.
Nannini, LJ; Lasserson, TJ; Poole, P (2012년 9월 12일). Nannini, Luis Javier, 편집. “Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease”. 《The Cochrane database of systematic reviews》 9: CD006829. doi:10.1002/14651858.CD006829.pub2. PMID 22972099.
Karner C; Chong J; Poole P (2012). Karner, Charlotta, 편집. “Tiotropium versus placebo for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 7: CD009285. doi:10.1002/14651858.CD009285.pub2. PMID 22786525.
Cheyne L; Irvin-Sellers MJ; White J (2013년 9월 16일). Cheyne, Leanne, 편집. “Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease”. 《Cochrane Database of Systematic Reviews》 9 (9): CD009552. doi:10.1002/14651858.CD009552.pub2. PMID 24043433.
Karner, C; Chong, J; Poole, P (2012년 7월 11일). Karner, Charlotta, 편집. “Tiotropium versus placebo for chronic obstructive pulmonary disease”. 《The Cochrane database of systematic reviews》 7: CD009285. doi:10.1002/14651858.CD009285.pub2. PMID 22786525.
Singh S; Loke YK; Furberg CD (September 2008). “Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis”. 《JAMA》 300 (12): 1439–50. doi:10.1001/jama.300.12.1439. PMID 18812535.
Singh S; Loke YK; Enright P; Furberg CD (January 2013). “Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications”. 《Thorax》 68 (1): 114–6. doi:10.1136/thoraxjnl-2011-201275. PMID 22764216.
Jones, P (Apr 2013). “Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.”. 《Advances in therapy》 30 (4): 354–68. doi:10.1007/s12325-013-0019-2. PMID 23553509.
Cazzola, M; Page, CP; Matera, MG (Jun 2013). “Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.”. 《Expert opinion on pharmacotherapy》 14 (9): 1205–14. doi:10.1517/14656566.2013.789021. PMID 23566013.
Gartlehner G; Hansen RA; Carson SS; Lohr KN (2006). “Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes”. 《Ann Fam Med》 4 (3): 253–62. doi:10.1370/afm.517. PMC 1479432. PMID 16735528.
Shafazand S (June 2013). “ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD”. 《Ann. Intern. Med.》 158 (12): JC2. doi:10.7326/0003-4819-158-12-201306180-02002. PMID 23778926.
Herath, SC; Poole, P (2013년 11월 28일). “Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).”. 《The Cochrane database of systematic reviews》 11: CD009764. doi:10.1002/14651858.CD009764.pub2. PMID 24288145.
Simoens, S; Laekeman, G; Decramer, M (May 2013). “Preventing COPD exacerbations with macrolides: a review and budget impact analysis”. 《Respiratory medicine》 107 (5): 637–48. doi:10.1016/j.rmed.2012.12.019. PMID 23352223.
Barr RG; Rowe BH; Camargo CA (2003). Barr, R Graham, 편집. “Methylxanthines for exacerbations of chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (2): CD002168. doi:10.1002/14651858.CD002168. PMID 12804425.
Bradley JM; O'Neill B (2005). Bradley, Judy M, 편집. “Short-term ambulatory oxygen for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (4): CD004356. doi:10.1002/14651858.CD004356.pub3. PMID 16235359.
Uronis H; McCrory DC; Samsa G; Currow D; Abernethy A (2011). Abernethy, Amy, 편집. “Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (6): CD006429. doi:10.1002/14651858.CD006429.pub2. PMID 21678356.
O'Driscoll, BR; Howard, LS; Davison, AG; British Thoracic, Society (October 2008). “BTS guideline for emergency oxygen use in adult patients”. 《Thorax》 63 (Suppl 6): vi1–68. doi:10.1136/thx.2008.102947. PMID 18838559.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA (2012). Vollenweider, Daniela J, 편집. “Antibiotics for exacerbations of chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 12: CD010257. doi:10.1002/14651858.CD010257. PMID 23235687.
Jeppesen, E; Brurberg, KG; Vist, GE; Wedzicha, JA; Wright, JJ; Greenstone, M; Walters, JA (2012년 5월 16일). “Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.”. 《The Cochrane database of systematic reviews》 5: CD003573. doi:10.1002/14651858.CD003573.pub2. PMID 22592692.
Murray CJ; Vos T; Lozano R; Naghavi M; Flaxman AD; Michaud C; Ezzati M; Shibuya K; Salomon JA; 외. (December 2012). “Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010”. 《Lancet》 380 (9859): 2197–223. doi:10.1016/S0140-6736(12)61689-4. PMID 23245608.
Vos T; Flaxman AD; Naghavi M; Lozano R; Michaud C; Ezzati M; Shibuya K; Salomon JA; Abdalla S; Aboyans V; 외. (December 2012). “Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010”. 《Lancet》 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID 23245607.
Lozano R,; Naghavi M; Foreman K; Lim S; Shibuya K; Aboyans V; Abraham J; Adair T; Aggarwal R; 외. (December 2012). “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010”. 《Lancet》 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
Rycroft CE; Heyes A; Lanza L; Becker K (2012). “Epidemiology of chronic obstructive pulmonary disease: a literature review”. 《Int J Chron Obstruct Pulmon Dis》 7: 457–94. doi:10.2147/COPD.S32330. PMC 3422122. PMID 22927753.
Simpson CR; Hippisley-Cox J; Sheikh A (2010). “Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients”. 《Brit J Gen Pract》 60 (576): 483–8. doi:10.3399/bjgp10X514729. PMC 2894402. PMID 20594429.
Ziment, Irwin (1991). “History of the Treatment of Chronic Bronchitis”. 《Respiration》 58 (Suppl 1): 37–42. doi:10.1159/000195969. PMID 1925077.
Petty TL (2006). “The history of COPD”. 《Int J Chron Obstruct Pulmon Dis》 1 (1): 3–14. doi:10.2147/copd.2006.1.1.3. PMC 2706597. PMID 18046898.
Fishman AP (May 2005). “One hundred years of chronic obstructive pulmonary disease”. 《Am. J. Respir. Crit. Care Med.》 171 (9): 941–8. doi:10.1164/rccm.200412-1685OE. PMID 15849329.
Inamdar, AC; Inamdar, AA (Oct 2013). “Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.”. 《Experimental lung research》 39 (8): 315–27. doi:10.3109/01902148.2013.816803. PMID 23992090.
Conese, M; Piro, D; Carbone, A; Castellani, S; Di Gioia, S (2014). “Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity.”. 《TheScientificWorldJournal》 2014: 859817. doi:10.1155/2014/859817. PMC 3916026. PMID 24563632.
Wright, JL; Churg, A (December 2002). “Animal models of cigarette smoke-induced COPD”. 《Chest》 122 (6 Suppl): 301S–6S. doi:10.1378/chest.122.6_suppl.301S. PMID 12475805.
Churg, A; Wright, JL (2007). “Animal models of cigarette smoke-induced chronic obstructive lung disease”. 《Contributions to microbiology》. Contributions to Microbiology 14: 113–25. doi:10.1159/000107058. ISBN 3-8055-8332-X. PMID 17684336.
Marinkovic D; Aleksic-Kovacevic S; Plamenac P (2007). “Cellular basis of chronic obstructive pulmonary disease in horses”. 《Int. Rev. Cytol.》. International Review of Cytology 257: 213–47. doi:10.1016/S0074-7696(07)57006-3. ISBN 978-0-12-373701-4. PMID 17280899.

ebmedicine.net

Gruber, Phillip (November 2008). “The Acute Presentation of Chronic Obstructive Pulmonary Disease In the Emergency Department: A Challenging Oxymoron”. 《Emergency Medicine Practice》 10 (11).

goldcopd.org

Vestbo, Jørgen (2013). 〈Definition and Overview〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 1–7쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
Vestbo, Jørgen (2013). 〈Diagnosis and Assessment〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 9–17쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
Vestbo, Jørgen (2013). 〈Management of Exacerbations〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 39–45쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
Vestbo, Jørgen (2013). 〈Introduction〉. 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》 (PDF). Global Initiative for Chronic Obstructive Lung Disease. xiii–xv. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2013년 11월 29일에 확인함.
Vestbo, Jørgen (2013). 〈Management of Stable COPD〉. 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》 (PDF). Global Initiative for Chronic Obstructive Lung Disease. 31–8쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2013년 11월 29일에 확인함.
Vestbo, Jørgen (2013). 〈Therapeutic Options〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 19–30쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.

google.ca

books.google.ca

Lomborg, Bjørn (2013). 《Global problems, local solutions : costs and benefits》. Cambridge University Pres. 143쪽. ISBN 978-1-107-03959-9.
Morrison, [edited by] Nathan E. Goldstein, R. Sean (2013). 《Evidence-based practice of palliative medicine》. Philadelphia: Elsevier/Saunders. 124쪽. ISBN 978-1-4377-3796-7.
〈Cor pulmonale〉. 《Professional guide to diseases》 9판. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 2009. 120–2쪽. ISBN 978-0-7817-7899-2.
Mandell, editors, James K. Stoller, Franklin A. Michota, Jr., Brian F. (2009). 《The Cleveland Clinic Foundation intensive review of internal medicine》 5판. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 419쪽. ISBN 978-0-7817-9079-6.
Spiro, Stephen (2012). 《Clinical respiratory medicine expert consult》 4판. Philadelphia, PA: Saunders. Chapter 43쪽. ISBN 978-1-4557-2329-4.
Ward, Helen (2012). 《Oxford Handbook of Epidemiology for Clinicians》. Oxford University Press. 289–290쪽. ISBN 978-0-19-165478-7.
Rennard, Stephen (2013). 《Clinical management of chronic obstructive pulmonary disease》 2판. New York: Informa Healthcare. 23쪽. ISBN 978-0-8493-7588-0.
Goldman, Lee (2012). 《Goldman's Cecil medicine》 24판. Philadelphia: Elsevier/Saunders. 537쪽. ISBN 978-1-4377-1604-7.
Laine, Christine (2009). 《In the Clinic: Practical Information about Common Health Problems》. ACP Press. 226쪽. ISBN 978-1-934465-64-6.
Barnes, Peter J.; Drazen, Jeffrey M.; Rennard, Stephen I.; Thomson, Neil C., 편집. (2009). 〈Relationship between cigarette smoking and occupational exposures〉. 《Asthma and COPD: Basic Mechanisms and Clinical Management》. Amsterdam: Academic. 464쪽. ISBN 978-0-12-374001-4.
Dhar, Raja (2011). 《Textbook of pulmonary and critical care medicine》. New Delhi: Jaypee Brothers Medical Publishers. 1056쪽. ISBN 978-93-5025-073-0.
Palange, Paolo (2013). 《ERS Handbook of Respiratory Medicine》. European Respiratory Society. 194쪽. ISBN 978-1-84984-041-5.
Lötvall, Jan (2011). 《Advances in combination therapy for asthma and COPD》. Chichester, West Sussex: John Wiley & Sons. 251쪽. ISBN 978-1-119-97846-6.
Barnes, Peter (2009). 《Asthma and COPD : basic mechanisms and clinical management》 2판. Amsterdam: Academic. 837쪽. ISBN 978-0-12-374001-4.
Hanania, Nicola (2010년 12월 9일). 《COPD a Guide to Diagnosis and Clinical Management》 1판. Totowa, NJ: Springer Science+Business Media, LLC. 197쪽. ISBN 978-1-59745-357-8.
Currie, Graeme P. (2010). 《ABC of COPD》 2판. Chichester, West Sussex, UK: Wiley-Blackwell, BMJ Books. 32쪽. ISBN 978-1-4443-2948-3.
Young, Vincent B. (2010). 《Blueprints medicine》 5판. Philadelphia: Wolters Kluwer Health/Lippincott William & Wilkins. 69쪽. ISBN 978-0-7817-8870-0.
Smith, Barbara K. Timby, Nancy E. (2005). 《Essentials of nursing : care of adults and children》. Philadelphia: Lippincott Williams & Wilkins. 338쪽. ISBN 978-0-7817-5098-1.
Rom, William N.; Markowitz, Steven B., 편집. (2007). 《Environmental and occupational medicine》 4판. Philadelphia: Wolters Kluwer/Lippincott Williams & Wilkins. 521–2쪽. ISBN 978-0-7817-6299-1.
George, Ronald B. (2005). 《Chest medicine : essentials of pulmonary and critical care medicine》 5판. Philadelphia, PA: Lippincott Williams & Wilkins. 172쪽. ISBN 978-0-7817-5273-2.
Chapman, Stephen (2009). 《Oxford handbook of respiratory medicine》 2판. Oxford: Oxford University Press. 707쪽. ISBN 978-0-19-954516-2.
Blackler, Laura (2007). 《Managing chronic obstructive pulmonary disease》. Chichester, England: John Wiley & Sons. 49쪽. ISBN 978-0-470-51798-7.
Jindal, Surinder K (2013). 《Chronic Obstructive Pulmonary Disease》. Jaypee Brothers Medical. 139쪽. ISBN 978-93-5090-353-7.
Medicine, prepared by the Department of Medicine, Washington University School of (2009). 《The Washington manual general internal medicine subspecialty consult.》 2판. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 96쪽. ISBN 978-0-7817-9155-7.
Yuh-Chin, T. Huang (2012년 10월 28일). 《A clinical guide to occupational and environmental lung diseases》. [New York]: Humana Press. 266쪽. ISBN 978-1-62703-149-3.
Weinberger, Steven E. (2013년 5월 8일). 《Principles of pulmonary medicine》 6판. Philadelphia: Elsevier/Saunders. 165쪽. ISBN 978-1-62703-149-3.
Des Jardins, Terry (2013). 《Clinical Manifestations & Assessment of Respiratory Disease》 6판. Elsevier Health Sciences. 176쪽. ISBN 978-0-323-27749-5.
Nici, Linda (2011). 《Chronic Obstructive Pulmonary Disease: Co-Morbidities and Systemic Consequences》. Springer. 78쪽. ISBN 978-1-60761-673-3.
Akers, R. Michael; Denbow, D. Michael (2008). 《Anatomy and Physiology of Domestic Animals》. Arnes, AI: Wiley. 852쪽. ISBN 978-1-118-70115-7.

gov.uk

《An outcomes strategy for people with chronic obstructive pulmonary disease (COPD) and asthma in England》 (PDF). Department of Health. 2011년 7월 18일. 5쪽. 2013년 11월 27일에 확인함.

hse.gov.uk

“Wet cutting”. Health and Safety Executive. 2013년 11월 29일에 확인함.

mhprofessional.com

Wright, Joanne L.; Churg, Andrew (2008). 〈Pathologic Features of Chronic Obstructive Pulmonary Disease: Diagnostic Criteria and Differential Diagnosis〉 (PDF). Fishman, Alfred; Elias, Jack; Fishman, Jay; Grippi, Michael; Senior, Robert; Pack, Allan. 《Fishman's Pulmonary Diseases and Disorders》 4판. New York: McGraw-Hill. 693–705쪽. ISBN 978-0-07-164109-8. 2016년 3월 3일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.

nhs.uk

“Why is smoking addictive?”. 《NHS Choices》. 2011년 12월 29일. 2013년 11월 29일에 확인함.

nice.org.uk

National Institute for Health and Clinical Excellence. Clinical guideline 101: Chronic Obstructive Pulmonary Disease. London, June 2010.
National Institute for Health and Clinical Excellence. Clinical guideline 101: Chronic Obstructive Pulmonary Disease. London, June 2010.

nih.gov

ncbi.nlm.nih.gov

Vogelmeier CF; Criner GJ; Martinez FJ; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Chen R; Decramer M; Fabbri LM; Frith P; Halpin DM; López Varela MV; Nishimura M; Roche N; Rodriguez-Roisin R; Sin DD; Singh D; Stockley R; Vestbo J; Wedzicha JA; Agusti A (April 2017). “Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary”. 《Respirology》 22 (3): 575–601. doi:10.1111/resp.13012. PMID 28150362.
Decramer M; Janssens W; Miravitlles M (April 2012). “Chronic obstructive pulmonary disease”. 《Lancet》 379 (9823): 1341–51. doi:10.1016/S0140-6736(11)60968-9. PMID 22314182.
Nathell L; Nathell M; Malmberg P; Larsson K (2007). “COPD diagnosis related to different guidelines and spirometry techniques”. 《Respir. Res.》 8 (1): 89. doi:10.1186/1465-9921-8-89. PMC 2217523. PMID 18053200.
Rabe KF; Hurd S; Anzueto A; Barnes PJ; Buist SA; Calverley P; Fukuchi Y; Jenkins C; Rodriguez-Roisin R; van Weel C; Zielinski J (September 2007). “Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary”. 《Am. J. Respir. Crit. Care Med.》 176 (6): 532–55. doi:10.1164/rccm.200703-456SO. PMID 17507545.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (October 2016). “Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
GBD 2015 Mortality and Causes of Death Collaborators (October 2016). “Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015”. 《Lancet》 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Mathers CD; Loncar D (November 2006). “Projections of Global Mortality and Burden of Disease from 2002 to 2030”. 《PLoS Med.》 3 (11): e442. doi:10.1371/journal.pmed.0030442. PMC 1664601. PMID 17132052.
Mahler DA (2006). “Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease”. 《Proceedings of the American Thoracic Society》 3 (3): 234–8. doi:10.1513/pats.200509-103SF. PMID 16636091.
Holland AE; Hill CJ; Jones AY; McDonald CF (2012). Holland, Anne E, 편집. “Breathing exercises for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 10: CD008250. doi:10.1002/14651858.CD008250.pub2. PMID 23076942.
Weitzenblum E; Chaouat A (2009). “Cor pulmonale”. 《Chron Respir Dis》 6 (3): 177–85. doi:10.1177/1479972309104664. PMID 19643833.
Brulotte CA; Lang ES (May 2012). “Acute exacerbations of chronic obstructive pulmonary disease in the emergency department”. 《Emerg. Med. Clin. North Am.》 30 (2): 223–47, vii. doi:10.1016/j.emc.2011.10.005. PMID 22487106.
Laniado-Laborín, R (January 2009). “Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21st century”. 《International journal of environmental research and public health》 6 (1): 209–24. doi:10.3390/ijerph6010209. PMC 2672326. PMID 19440278.
Kennedy SM; Chambers R; Du W; Dimich-Ward H (December 2007). “Environmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?”. 《Proceedings of the American Thoracic Society》 4 (8): 692–4. doi:10.1513/pats.200707-094SD. PMID 18073405.
Pirozzi C; Scholand MB (July 2012). “Smoking cessation and environmental hygiene”. 《Med. Clin. North Am.》 96 (4): 849–67. doi:10.1016/j.mcna.2012.04.014. PMID 22793948.
Halbert RJ; Natoli JL; Gano A; Badamgarav E; Buist AS; Mannino DM (September 2006). “Global burden of COPD: systematic review and meta-analysis”. 《Eur. Respir. J.》 28 (3): 523–32. doi:10.1183/09031936.06.00124605. PMID 16611654.
Devereux, Graham (2006). “Definition, epidemiology and risk factors”. 《BMJ》 332 (7550): 1142–4. doi:10.1136/bmj.332.7550.1142. PMC 1459603. PMID 16690673.
Rushton, Lesley (2007). “Chronic Obstructive Pulmonary Disease and Occupational Exposure to Silica”. 《Reviews on Environmental Health》 22 (4): 255–72. doi:10.1515/REVEH.2007.22.4.255. PMID 18351226.
Foreman MG; Campos M; Celedón JC (July 2012). “Genes and chronic obstructive pulmonary disease”. 《Med. Clin. North Am.》 96 (4): 699–711. doi:10.1016/j.mcna.2012.02.006. PMC 3399759. PMID 22793939.
Brode SK; Ling SC; Chapman KR (September 2012). “Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease”. 《CMAJ》 184 (12): 1365–71. doi:10.1503/cmaj.111749. PMC 3447047. PMID 22761482.
Beasley, V; Joshi, PV; Singanayagam, A; Molyneaux, PL; Johnston, SL; Mallia, P (2012). “Lung microbiology and exacerbations in COPD”. 《International journal of chronic obstructive pulmonary disease》 7: 555–69. doi:10.2147/COPD.S28286. PMC 3437812. PMID 22969296.
Calverley PM; Koulouris NG (2005). “Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology”. 《Eur Respir J》 25 (1): 186–199. doi:10.1183/09031936.04.00113204. PMID 15640341.
O'Donnell DE (2006). “Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease”. 《The Proceedings of the American Thoracic Society》 3 (2): 180–4. doi:10.1513/pats.200508-093DO. PMID 16565429.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P (August 2011). “Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society”. 《Ann. Intern. Med.》 155 (3): 179–91. doi:10.7326/0003-4819-155-3-201108020-00008. PMID 21810710.
Torres M; Moayedi S (May 2007). “Evaluation of the acutely dyspneic elderly patient”. 《Clin. Geriatr. Med.》 23 (2): 307–25, vi. doi:10.1016/j.cger.2007.01.007. PMID 17462519.
Mackay AJ; Hurst JR (July 2012). “COPD exacerbations: causes, prevention, and treatment”. 《Med. Clin. North Am.》 96 (4): 789–809. doi:10.1016/j.mcna.2012.02.008. PMID 22793945.
Poole PJ; Chacko E; Wood-Baker RW; Cates CJ (2006). Poole, Phillippa, 편집. “Influenza vaccine for patients with chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (1): CD002733. doi:10.1002/14651858.CD002733.pub2. PMID 16437444.
Jiménez-Ruiz CA; Fagerström KO (March 2013). “Smoking cessation treatment for COPD smokers: the role of counselling”. 《Monaldi Arch Chest Dis》 79 (1): 33–7. PMID 23741944.
Tønnesen P (March 2013). “Smoking cessation and COPD”. 《Eur Respir Rev》 22 (127): 37–43. doi:10.1183/09059180.00007212. PMID 23457163.
Drummond MB; Dasenbrook EC; Pitz MW; Murphy DJ; Fan E (November 2008). “Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis”. 《JAMA》 300 (20): 2407–16. doi:10.1001/jama.2008.717. PMID 19033591.
Carlucci A; Guerrieri A; Nava S (December 2012). “Palliative care in COPD patients: is it only an end-of-life issue?”. 《Eur Respir Rev》 21 (126): 347–54. doi:10.1183/09059180.00001512. PMID 23204123.
Puhan MA; Gimeno-Santos E; Scharplatz M; Troosters T; Walters EH; Steurer J (2011). Puhan, Milo A, 편집. “Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (10): CD005305. doi:10.1002/14651858.CD005305.pub3. PMID 21975749.
Lacasse Y; Goldstein R; Lasserson TJ; Martin S (2006). Lacasse, Yves, 편집. “Pulmonary rehabilitation for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (4): CD003793. doi:10.1002/14651858.CD003793.pub2. PMID 17054186.
Ferreira IM; Brooks D; White J; Goldstein R (2012). Ferreira, Ivone M, 편집. “Nutritional supplementation for stable chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 12: CD000998. doi:10.1002/14651858.CD000998.pub3. PMID 23235577.
van Dijk WD; van den Bemt L; van Weel C (2013). “Megatrials for bronchodilators in chronic obstructive pulmonary disease (COPD) treatment: time to reflect”. 《J Am Board Fam Med》 26 (2): 221–4. doi:10.3122/jabfm.2013.02.110342. PMID 23471939.
Liesker JJ; Wijkstra PJ; Ten Hacken NH; Koëter GH; Postma DS; Kerstjens HA (February 2002). “A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD”. 《Chest》 121 (2): 597–608. doi:10.1378/chest.121.2.597. PMID 11834677. 2015년 9월 28일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.
Chong J; Karner C; Poole P (2012). Chong, Jimmy, 편집. “Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 9: CD009157. doi:10.1002/14651858.CD009157.pub2. PMID 22972134.
Karner C; Cates CJ (2012). Karner, Charlotta, 편집. “Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 4: CD008989. doi:10.1002/14651858.CD008989.pub2. PMID 22513969.
Cave, AC.; Hurst, MM. (May 2011). “The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis”. 《Pharmacol Ther》 130 (2): 114–43. doi:10.1016/j.pharmthera.2010.12.008. PMID 21276815.
Spencer, S; Karner, C; Cates, CJ; Evans, DJ (2011년 12월 7일). Spencer, Sally, 편집. “Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease”. 《The Cochrane database of systematic reviews》 (12): CD007033. doi:10.1002/14651858.CD007033.pub3. PMID 22161409.
Wang, J; Nie, B; Xiong, W; Xu, Y (April 2012). “Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis”. 《Journal of clinical pharmacy and therapeutics》 37 (2): 204–11. doi:10.1111/j.1365-2710.2011.01285.x. PMID 21740451.
Decramer ML; Hanania NA; Lötvall JO; Yawn BP (2013). “The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease”. 《Int J Chron Obstruct Pulmon Dis》 8: 53–64. doi:10.2147/COPD.S39018. PMC 3558319. PMID 23378756.
Nannini, LJ; Lasserson, TJ; Poole, P (2012년 9월 12일). Nannini, Luis Javier, 편집. “Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease”. 《The Cochrane database of systematic reviews》 9: CD006829. doi:10.1002/14651858.CD006829.pub2. PMID 22972099.
Karner C; Chong J; Poole P (2012). Karner, Charlotta, 편집. “Tiotropium versus placebo for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 7: CD009285. doi:10.1002/14651858.CD009285.pub2. PMID 22786525.
Cheyne L; Irvin-Sellers MJ; White J (2013년 9월 16일). Cheyne, Leanne, 편집. “Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease”. 《Cochrane Database of Systematic Reviews》 9 (9): CD009552. doi:10.1002/14651858.CD009552.pub2. PMID 24043433.
Karner, C; Chong, J; Poole, P (2012년 7월 11일). Karner, Charlotta, 편집. “Tiotropium versus placebo for chronic obstructive pulmonary disease”. 《The Cochrane database of systematic reviews》 7: CD009285. doi:10.1002/14651858.CD009285.pub2. PMID 22786525.
Singh S; Loke YK; Furberg CD (September 2008). “Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis”. 《JAMA》 300 (12): 1439–50. doi:10.1001/jama.300.12.1439. PMID 18812535.
Singh S; Loke YK; Enright P; Furberg CD (January 2013). “Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications”. 《Thorax》 68 (1): 114–6. doi:10.1136/thoraxjnl-2011-201275. PMID 22764216.
Jones, P (Apr 2013). “Aclidinium bromide twice daily for the treatment of chronic obstructive pulmonary disease: a review.”. 《Advances in therapy》 30 (4): 354–68. doi:10.1007/s12325-013-0019-2. PMID 23553509.
Cazzola, M; Page, CP; Matera, MG (Jun 2013). “Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.”. 《Expert opinion on pharmacotherapy》 14 (9): 1205–14. doi:10.1517/14656566.2013.789021. PMID 23566013.
Gartlehner G; Hansen RA; Carson SS; Lohr KN (2006). “Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes”. 《Ann Fam Med》 4 (3): 253–62. doi:10.1370/afm.517. PMC 1479432. PMID 16735528.
Shafazand S (June 2013). “ACP Journal Club. Review: inhaled medications vary substantively in their effects on mortality in COPD”. 《Ann. Intern. Med.》 158 (12): JC2. doi:10.7326/0003-4819-158-12-201306180-02002. PMID 23778926.
Mammen MJ; Sethi S (2012). “Macrolide therapy for the prevention of acute exacerbations in chronic obstructive pulmonary disease”. 《Pol. Arch. Med. Wewn.》 122 (1–2): 54–9. PMID 22353707.
Herath, SC; Poole, P (2013년 11월 28일). “Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).”. 《The Cochrane database of systematic reviews》 11: CD009764. doi:10.1002/14651858.CD009764.pub2. PMID 24288145.
Simoens, S; Laekeman, G; Decramer, M (May 2013). “Preventing COPD exacerbations with macrolides: a review and budget impact analysis”. 《Respiratory medicine》 107 (5): 637–48. doi:10.1016/j.rmed.2012.12.019. PMID 23352223.
Barr RG; Rowe BH; Camargo CA (2003). Barr, R Graham, 편집. “Methylxanthines for exacerbations of chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (2): CD002168. doi:10.1002/14651858.CD002168. PMID 12804425.
COPD Working, Group (2012). “Long-term oxygen therapy for patients with chronic obstructive pulmonary disease (COPD): an evidence-based analysis”. 《Ontario health technology assessment series》 12 (7): 1–64. PMC 3384376. PMID 23074435.
Bradley JM; O'Neill B (2005). Bradley, Judy M, 편집. “Short-term ambulatory oxygen for chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (4): CD004356. doi:10.1002/14651858.CD004356.pub3. PMID 16235359.
Uronis H; McCrory DC; Samsa G; Currow D; Abernethy A (2011). Abernethy, Amy, 편집. “Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 (6): CD006429. doi:10.1002/14651858.CD006429.pub2. PMID 21678356.
O'Driscoll, BR; Howard, LS; Davison, AG; British Thoracic, Society (October 2008). “BTS guideline for emergency oxygen use in adult patients”. 《Thorax》 63 (Suppl 6): vi1–68. doi:10.1136/thx.2008.102947. PMID 18838559.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA (2012). Vollenweider, Daniela J, 편집. “Antibiotics for exacerbations of chronic obstructive pulmonary disease”. 《Cochrane Database Syst Rev》 12: CD010257. doi:10.1002/14651858.CD010257. PMID 23235687.
Jeppesen, E; Brurberg, KG; Vist, GE; Wedzicha, JA; Wright, JJ; Greenstone, M; Walters, JA (2012년 5월 16일). “Hospital at home for acute exacerbations of chronic obstructive pulmonary disease.”. 《The Cochrane database of systematic reviews》 5: CD003573. doi:10.1002/14651858.CD003573.pub2. PMID 22592692.
Murray CJ; Vos T; Lozano R; Naghavi M; Flaxman AD; Michaud C; Ezzati M; Shibuya K; Salomon JA; 외. (December 2012). “Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010”. 《Lancet》 380 (9859): 2197–223. doi:10.1016/S0140-6736(12)61689-4. PMID 23245608.
Vos T; Flaxman AD; Naghavi M; Lozano R; Michaud C; Ezzati M; Shibuya K; Salomon JA; Abdalla S; Aboyans V; 외. (December 2012). “Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010”. 《Lancet》 380 (9859): 2163–96. doi:10.1016/S0140-6736(12)61729-2. PMID 23245607.
Lozano R,; Naghavi M; Foreman K; Lim S; Shibuya K; Aboyans V; Abraham J; Adair T; Aggarwal R; 외. (December 2012). “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010”. 《Lancet》 380 (9859): 2095–128. doi:10.1016/S0140-6736(12)61728-0. PMID 23245604.
Rycroft CE; Heyes A; Lanza L; Becker K (2012). “Epidemiology of chronic obstructive pulmonary disease: a literature review”. 《Int J Chron Obstruct Pulmon Dis》 7: 457–94. doi:10.2147/COPD.S32330. PMC 3422122. PMID 22927753.
Simpson CR; Hippisley-Cox J; Sheikh A (2010). “Trends in the epidemiology of chronic obstructive pulmonary disease in England: a national study of 51 804 patients”. 《Brit J Gen Pract》 60 (576): 483–8. doi:10.3399/bjgp10X514729. PMC 2894402. PMID 20594429.
Centers for Disease Control and Prevention (2012년 11월 23일). “Chronic Obstructive Pulmonary Disease Among Adults — United States, 2011”. 《Morbidity and Mortality Weekly Report》 61 (46): 938–43. PMID 23169314.
Torio CM; Andrews RM (2006). “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160”. 《Healthcare Cost and Utilization Project (HCUP) Statistical Briefs》 (Agency for Health Care Policy and Research). PMID 24199255. 2017년 3월 14일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.
Ziment, Irwin (1991). “History of the Treatment of Chronic Bronchitis”. 《Respiration》 58 (Suppl 1): 37–42. doi:10.1159/000195969. PMID 1925077.
Petty TL (2006). “The history of COPD”. 《Int J Chron Obstruct Pulmon Dis》 1 (1): 3–14. doi:10.2147/copd.2006.1.1.3. PMC 2706597. PMID 18046898.
Fishman AP (May 2005). “One hundred years of chronic obstructive pulmonary disease”. 《Am. J. Respir. Crit. Care Med.》 171 (9): 941–8. doi:10.1164/rccm.200412-1685OE. PMID 15849329.
Inamdar, AC; Inamdar, AA (Oct 2013). “Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.”. 《Experimental lung research》 39 (8): 315–27. doi:10.3109/01902148.2013.816803. PMID 23992090.
Conese, M; Piro, D; Carbone, A; Castellani, S; Di Gioia, S (2014). “Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity.”. 《TheScientificWorldJournal》 2014: 859817. doi:10.1155/2014/859817. PMC 3916026. PMID 24563632.
Wright, JL; Churg, A (December 2002). “Animal models of cigarette smoke-induced COPD”. 《Chest》 122 (6 Suppl): 301S–6S. doi:10.1378/chest.122.6_suppl.301S. PMID 12475805.
Churg, A; Wright, JL (2007). “Animal models of cigarette smoke-induced chronic obstructive lung disease”. 《Contributions to microbiology》. Contributions to Microbiology 14: 113–25. doi:10.1159/000107058. ISBN 3-8055-8332-X. PMID 17684336.
Marinkovic D; Aleksic-Kovacevic S; Plamenac P (2007). “Cellular basis of chronic obstructive pulmonary disease in horses”. 《Int. Rev. Cytol.》. International Review of Cytology 257: 213–47. doi:10.1016/S0074-7696(07)57006-3. ISBN 978-0-12-373701-4. PMID 17280899.
Miller MS; Tilley LP; Smith FW (January 1989). “Cardiopulmonary disease in the geriatric dog and cat”. 《Vet. Clin. North Am. Small Anim. Pract.》 19 (1): 87–102. PMID 2646821.

nhlbi.nih.gov

“What Are the Signs and Symptoms of COPD?”. National Heart, Lung, and Blood Institute. 2013년 7월 31일. 2013년 11월 29일에 확인함.
“COPD — Treatment”. U.S. National Heart Lung and Blood Institute. 2013년 7월 23일에 확인함.
“Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases” (PDF). National Heart, Lung, and Blood Institute. 2013년 10월 19일에 원본 문서 (PDF)에서 보존된 문서. 2014년 4월 23일에 확인함.

nlm.nih.gov

(영어) Chronic obstructive pulmonary disease - 메드라인플러스

plos.org

dx.plos.org

Mathers CD; Loncar D (November 2006). “Projections of Global Mortality and Burden of Disease from 2002 to 2030”. 《PLoS Med.》 3 (11): e442. doi:10.1371/journal.pmed.0030442. PMC 1664601. PMID 17132052.

reference.com

dictionary.reference.com

“Emphysema”. 《Dictionary.com》. 2013년 11월 21일에 확인함.

semanticscholar.org

Vogelmeier CF; Criner GJ; Martinez FJ; Anzueto A; Barnes PJ; Bourbeau J; Celli BR; Chen R; Decramer M; Fabbri LM; Frith P; Halpin DM; López Varela MV; Nishimura M; Roche N; Rodriguez-Roisin R; Sin DD; Singh D; Stockley R; Vestbo J; Wedzicha JA; Agusti A (April 2017). “Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary”. 《Respirology》 22 (3): 575–601. doi:10.1111/resp.13012. PMID 28150362.

thefreedictionary.com

medical-dictionary.thefreedictionary.com

“Pink Puffer - definition of Pink Puffer in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia”. Medical-dictionary.thefreedictionary.com. 2013년 7월 23일에 확인함.

thoracic.org

“COPD Assessment Test (CAT)”. American Thoracic Society. 2013년 11월 29일에 확인함.

web.archive.org

“Chronic obstructive pulmonary disease (COPD) Fact sheet N°315”. 《WHO》. January 2015. 2016년 3월 4일에 원본 문서에서 보존된 문서. 2016년 3월 4일에 확인함.
Vestbo, Jørgen (2013). 〈Definition and Overview〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 1–7쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
Vestbo, Jørgen (2013). 〈Diagnosis and Assessment〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 9–17쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
Vestbo, Jørgen (2013). 〈Management of Exacerbations〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 39–45쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
BTS COPD Consortium (2005). “Spirometry in practice - a practical guide to using spirometry in primary care”. 8–9쪽. 2014년 8월 26일에 원본 문서에서 보존된 문서. 2014년 8월 25일에 확인함.
Vestbo, Jørgen (2013). 〈Introduction〉. 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》 (PDF). Global Initiative for Chronic Obstructive Lung Disease. xiii–xv. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2013년 11월 29일에 확인함.
Vestbo, Jørgen (2013). 〈Management of Stable COPD〉. 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》 (PDF). Global Initiative for Chronic Obstructive Lung Disease. 31–8쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2013년 11월 29일에 확인함.
Liesker JJ; Wijkstra PJ; Ten Hacken NH; Koëter GH; Postma DS; Kerstjens HA (February 2002). “A systematic review of the effects of bronchodilators on exercise capacity in patients with COPD”. 《Chest》 121 (2): 597–608. doi:10.1378/chest.121.2.597. PMID 11834677. 2015년 9월 28일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.
Vestbo, Jørgen (2013). 〈Therapeutic Options〉 (PDF). 《Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease》. Global Initiative for Chronic Obstructive Lung Disease. 19–30쪽. 2013년 10월 4일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.
“Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases” (PDF). National Heart, Lung, and Blood Institute. 2013년 10월 19일에 원본 문서 (PDF)에서 보존된 문서. 2014년 4월 23일에 확인함.
Torio CM; Andrews RM (2006). “National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011: Statistical Brief #160”. 《Healthcare Cost and Utilization Project (HCUP) Statistical Briefs》 (Agency for Health Care Policy and Research). PMID 24199255. 2017년 3월 14일에 원본 문서에서 보존된 문서. 2015년 8월 18일에 확인함.
Wright, Joanne L.; Churg, Andrew (2008). 〈Pathologic Features of Chronic Obstructive Pulmonary Disease: Diagnostic Criteria and Differential Diagnosis〉 (PDF). Fishman, Alfred; Elias, Jack; Fishman, Jay; Grippi, Michael; Senior, Robert; Pack, Allan. 《Fishman's Pulmonary Diseases and Disorders》 4판. New York: McGraw-Hill. 693–705쪽. ISBN 978-0-07-164109-8. 2016년 3월 3일에 원본 문서 (PDF)에서 보존된 문서. 2015년 8월 18일에 확인함.

weforum.org

www3.weforum.org

Bloom, D (2011). 《The Global Economic Burden of Noncommunicable Diseases》 (PDF). World Economic Forum. 24쪽.

who.int

“Chronic obstructive pulmonary disease (COPD) Fact sheet N°315”. 《WHO》. January 2015. 2016년 3월 4일에 원본 문서에서 보존된 문서. 2016년 3월 4일에 확인함.
“The 10 leading causes of death in the world, 2000 and 2011”. World Health Organization. July 2013. 2013년 11월 29일에 확인함.
World Health Organization (2008). 《WHO Report on the Global Tobacco Epidemic 2008: The MPOWER Package》 (PDF). Geneva: World Health Organization. 268–309쪽. ISBN 92-4-159628-7.
《Policy Recommendations for Smoking Cessation and Treatment of Tobacco Dependence》. World Health Organization. 15–40쪽. ISBN 978-92-4-156240-9.
“WHO Disease and injury country estimates”. 《World Health Organization》. 2009. 2009년 11월 11일에 확인함.
“Chronic obstructive pulmonary disease (COPD) Fact sheet N°315”. WHO. November 2012.